These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 148320)

  • 1. Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer.
    Sakamoto S; Ogata J; Ikegami K; Maeda H
    Cancer Treat Rep; 1978 Mar; 62(3):453-4. PubMed ID: 148320
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration.
    Sakamoto S; Ogata J; Ikegami K; Maeda H
    Eur J Cancer (1965); 1980 Jan; 16(1):103-13. PubMed ID: 6444585
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcapsule chemoembolization therapy: a new approach to bladder cancer.
    Kato T
    Prog Clin Biol Res; 1984; 162B():359-63. PubMed ID: 6209723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Superficial bladder carcinoma -- trend of less aggressive therapies].
    Friedrich MG
    Aktuelle Urol; 2006 Jul; 37(4):254-6. PubMed ID: 16955957
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I study of neocarzinostatin in patients with acute leukemia.
    Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1978 Sep; 62(9):1363-5. PubMed ID: 150945
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical bacillus Calmette-Guérin combined with electromotive mitomycin for high-risk superficial bladder cancer.
    Bochner BH
    Nat Clin Pract Oncol; 2006 Sep; 3(9):474-5. PubMed ID: 16955082
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant therapy of carcinoma of the bladder.
    deVere White RW
    Semin Urol; 1990 Aug; 8(3):197-200. PubMed ID: 2204981
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of bladder cancer by neothramycin.
    Tsugaya M; Washida H; Hirao N; Hachisuka Y; Sakagami H; Iwase Y
    Hinyokika Kiyo; 1986 Oct; 32(10):1443-8. PubMed ID: 3565180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 13. [A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR recurrence of superficial bladder cancer].
    Kawamura S; Fujioka T; Kubo T; Yoshida I; Takata K
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):465-70. PubMed ID: 8678499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of bladder carcinoma with similar initial features that exhibited completely different clinical courses.
    Kakizoe T; Ohtani M; Tobisu K; Matsumoto K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1986 Mar; 16(1):73-6. PubMed ID: 2939269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravesical instillation of pirarubicin for a patient with bladder cancer and chronic renal failure: a case report].
    Tanomogi H; Masuda T; Yamamoto Y; Arima K; Matsuoka Y
    Hinyokika Kiyo; 1995 May; 41(5):391-3. PubMed ID: 7598041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocarzinostatin in cancer chemotherapy (review).
    Maeda H
    Anticancer Res; 1981; 1(3):175-86. PubMed ID: 6211130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for bladder cancer. Standard of care or unproven therapy?
    Bahnson RR; Smith D; Trump D
    Surg Oncol Clin N Am; 1995 Apr; 4(2):287. PubMed ID: 7796287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transurethral resection in the treatment of locally advanced cancer of the bladder].
    Shipilov VI; Pirtskhalaishvili GG
    Vopr Onkol; 1990; 36(11):1369-71. PubMed ID: 2281644
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical investigations of neocarzinostatin in Japan.
    Kimura I
    Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
    Kalsi J; Harland SJ; Feneley MR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.